The GLP is committed to full transparency. Download and review our 2019 Annual Report

Can we engineer soldiers to be immune to chemical attacks?

| | January 30, 2020
im
Image: AP
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Despite international bans, some countries, such as Syria, use deadly nerve agents against enemy soldiers and civilians. Existing treatments for these chemical weapon attacks must be given quickly and don’t always prevent convulsions or brain damage. Now, U.S. Army researchers have created a gene therapy that allows mice to make their own nerve agent–busting proteins, providing protection against the toxicants for months.

[Biochemist Moshe] Goldsmith and collaborators have tweaked an enzyme called paraoxonase 1 (PON1) so that it can help the body defang nerve agents faster. But the Army would need to produce and store large quantities of such “bioscavengers” for injection into soldiers and might need to find a way to shield the proteins from the immune system for them to be effective.

Related article:  Talking Biotech: Can genetically engineered cassava help African farmers?

So scientists at the U.S. Army Medical Research Institute of Chemical Defense took a different approach: Turn the liver into a factory for making a bioscavenger enzyme.

Mice injected with the DNA-ferrying virus soon had high blood levels of the synthetic PON1 enzyme, which remained stable for the 5-month study. The rodents survived nine normally lethal injections of nerve agents over 6 weeks, the Army team reports [January 22] in Science Translational Medicine.

Read the original post

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend